Literature DB >> 6866608

Screening for iron deficiency with the erythrocyte protoporphyrin test.

R Yip, S Schwartz, A S Deinard.   

Abstract

Elevation of erythrocyte protoporphyrin (EP) level is one of the consequences of iron deficiency. As the EP test has been established to be a screening test for lead poisoning, the screening capability of the EP test for iron deficiency was investigated. A total of 4,160 children between ages 6 months to 12 years had EP determined together with serum ferritin and hematocrit. Comparing the relationship of EP to serum ferritin and using a serum ferritin value less than or equal to 15 micrograms/L as the criterion of iron deficiency, the optimal cutoff limit for the EP test appears to be 35 micrograms/dL of whole blood. At this level, 88% of the subjects with low levels of serum ferritin can be detected (sensitivity), in contrast to the 53% detected at a higher cutoff value (greater than or equal to 50 micrograms/dL) used to screen for lead toxicity, or to the 59% detected by age-related hematocrit value. At an EP screening level of 35 micrograms/dL of whole blood, 90% of the subjects with normal serum ferritin level are correctly determined to be screen negative (specificity). The predictive value of low levels of serum ferritin for all subjects above screening level is 38%. In general, an elevated EP level, by itself, represents inadequate iron supply for hematopoiesis and signals iron deficiency regardless of whether the serum ferritin value is below the diagnostic level or not. A trial course of orally administered iron is suggested for children who are found to have an elevated EP value, with an increase in hemoglobin or hematocrit value serving, retrospectively, as confirmation of prior iron deficiency.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866608

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Lead toxicity and iron deficiency in Utah migrant children.

Authors:  S D Ratcliffe; J Lee; L J Lutz; F R Woolley; S Baxter; F Civish; M Johnson
Journal:  Am J Public Health       Date:  1989-05       Impact factor: 9.308

2.  Lead absorption in indoor firing range users.

Authors:  S E Valway; J W Martyny; J R Miller; M Cook; E J Mangione
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

3.  Erythrocyte protoporphyrin and blood lead levels of children from Jammu and Srinagar and papier mache trainees.

Authors:  P S Kaul; B Kaul
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

4.  Iron status in low birth weight infants on breast and formula feeding.

Authors:  Y Iwai; T Takanashi; Y Nakao; H Mikawa
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Prevalence of iron deficiency among Chinese children aged 6 to 36 months in Montreal.

Authors:  A Chan-Yip; K Gray-Donald
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

6.  Iron deficiency in Massachusetts communities: Socioeconomic and demographic risk factors among children.

Authors:  J D Sargent; T A Stukel; M A Dalton; J L Freeman; M J Brown
Journal:  Am J Public Health       Date:  1996-04       Impact factor: 9.308

7.  Lead exposure and child behavior.

Authors:  W G Sciarillo; G Alexander; K P Farrell
Journal:  Am J Public Health       Date:  1992-10       Impact factor: 9.308

8.  Effectiveness of zinc protoporphyrin/heme ratio for screening iron deficiency in preschool-aged children.

Authors:  Kyeong Hee Yu
Journal:  Nutr Res Pract       Date:  2011-02-28       Impact factor: 1.926

9.  Optimal management of iron deficiency anemia due to poor dietary intake.

Authors:  Kattalin Aspuru; Carlos Villa; Fernando Bermejo; Pilar Herrero; Santiago García López
Journal:  Int J Gen Med       Date:  2011-10-31

10.  Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children.

Authors:  H A Ruff; M E Markowitz; P E Bijur; J F Rosen
Journal:  Environ Health Perspect       Date:  1996-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.